Orthobiologics as an Adjunct in Treatment of Femoroacetabular Impingement Syndrome: Cell-Based Therapies Facilitate Improved Postoperative Outcomes in the Setting of Acetabular Chondral Lesions – A Systematic Review

Orthobiologics as an Adjunct in Treatment of Femoroacetabular Impingement Syndrome: Cell-Based Therapies Facilitate Improved Postoperative Outcomes in the Setting of Acetabular Chondral Lesions – A Systematic Review

Authors: George T, Curley AJ, Saeed SK, Kuhns BD, Parsa A, Domb BG

Journal

Knee Surgery, Sports Traumatology, Arthroscopy, December 2023

Objective

To evaluate the effectiveness of orthobiologics (e.g., platelet-rich plasma, hyaluronic acid, and cell-based therapies) in treating femoroacetabular impingement syndrome (FAIS), especially in cases with acetabular cartilage damage.

Key Findings

• All studies reviewed showed improvements in patient-reported outcomes (PROMs) after treatment.
• Cell-based therapies (CBT) showed the most promising results, especially for acetabular cartilage damage.
• Platelet-rich plasma (PRP) and CBT were often used alongside labral repairs during hip arthroscopy.
• CBT showed better outcomes than PRP in some studies.

Conclusion

Using cell-based therapies as part of the treatment plan for FAIS, especially in cases involving joint cartilage damage, can enhance postoperative recovery and improve patient outcomes.

What Does This Mean For Patients

If you have FAIS with cartilage damage, cell-based therapies could significantly improve your recovery, leading to better pain relief and functional outcomes.